Jose L Lopez-Ribot
Overview
Explore the profile of Jose L Lopez-Ribot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
5546
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramage G, Kean R, Rautemaa-Richardson R, Williams C, Lopez-Ribot J
Nat Rev Microbiol
. 2025 Feb;
PMID: 39910237
Increased use of implanted medical devices, use of immunosuppressants and an ageing population have driven the rising frequency of fungal biofilm-related diseases. Fungi are now recognized by the World Health...
2.
Romo J, Lopez-Ribot J
Cell Host Microbe
. 2024 May;
32(5):625-626.
PMID: 38723598
Fungi colonize the mammalian gastrointestinal (GI) tract and can adopt both commensal and opportunistic lifestyles. In a recent issue of Nature, Liang et al. unraveled the complex interplay between Candida...
3.
Ajetunmobi O, Wall G, Vidal Bonifacio B, Martinez Delgado L, Chaturvedi A, Najvar L, et al.
J Fungi (Basel)
. 2023 Sep;
9(9).
PMID: 37754987
Candidiasis is one of the most frequent nosocomial infections affecting an increasing number of at-risk patients. remains the most frequent causative agent of candidiasis, but, in the last decade, has...
4.
McMahon C, Esqueda M, Yu J, Wall G, Romo J, Vila T, et al.
J Fungi (Basel)
. 2023 Jul;
9(7).
PMID: 37504711
Automated imaging techniques have been in increasing demand for the more advanced analysis and efficient characterization of cellular phenotypes. The success of the image-based profiling method hinges on assays that...
5.
Ajetunmobi O, Chaturvedi A, Badali H, Vaccaro A, Najvar L, Wormley Jr F, et al.
APMIS
. 2023 Jun;
131(11):613-625.
PMID: 37337909
Candida spp. are opportunistic yeasts capable of forming biofilms, which contribute to resistance, increasing the urgency for new effective antifungal therapies. Repurposing existing drugs could significantly accelerate the development of...
6.
Ajetunmobi O, Badali H, Romo J, Ramage G, Lopez-Ribot J
Biofilm
. 2023 May;
5:100126.
PMID: 37193227
Virtually all species linked to clinical candidiasis are capable of forming highly resistant biofilms on different types of surfaces, which poses an additional significant threat and further complicates therapy of...
7.
Ajetunmobi O, Wall G, Bonifacio B, Montelongo-Jauregui D, Lopez-Ribot J
Methods Mol Biol
. 2023 Apr;
2658:53-64.
PMID: 37024695
Candidiasis, infections caused by Candida spp., represents one of the most common nosocomial infections afflicting an expanding number of compromised patients. Antifungal therapeutic options are few and show limited efficacy....
8.
Cheng T, Torres N, Chen P, Srinivasan A, Cardona S, Lee G, et al.
mSphere
. 2021 Apr;
6(2).
PMID: 33910992
Many microbes in their natural habitats are found in biofilm ecosystems attached to surfaces and not as free-floating (planktonic) organisms. Furthermore, it is estimated that nearly 80% of human infections...
9.
Wall G, Chen E, Hull M, Lopez-Ribot J
Front Cell Infect Microbiol
. 2020 Dec;
10:597931.
PMID: 33324579
is an emerging yeast which, since its first isolation about a decade ago, has spread rapidly and triggered major infectious outbreaks in health care facilities around the world. strains often...
10.
Vazquez-Munoz R, Arellano-Jimenez M, Lopez-Ribot J
BMC Biomed Eng
. 2020 Oct;
2:11.
PMID: 33073175
Background: Bismuth compounds are known for their activity against multiple microorganisms; yet, the antibiotic properties of bismuth nanoparticles (BiNPs) remain poorly explored. The objective of this work is to further...